F-group (family)
3415.1.1.1 Nucleos_tra2_N,Nucleos_tra2_C,Gate
Ligands and drugs
107
Member domains
53
with ligand contacts (≤ 4 Å)
49.5% of members
23
with DrugDomain annotations
21.5% of members
11
with a DrugBank compound
10.3% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3415.1.1.1 belongs to X-group 3415 Concentrative nucleoside transporter, which has 2 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02745 | URI | Uridine | 5 |
| DB00441 | GEO | Gemcitabine | 1 |
| DB00640 | ADN | Adenosine | 1 |
| DB00811 | RBV | Ribavirin | 1 |
| DB01629 | 5UD | 5-fluorouridine | 1 |
| DB02097 | CTN | Cytidine | 1 |
| DB03068 | ZE8 | Zebularine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 27 |
| LBN | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine | 21 |
| XMO | N-hydroxy-5'-O-(2-methylpropanoyl)cytidine | 15 |
| 6ZL | 2-{[(4-O-alpha-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]methyl}-2-octyldecyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside | 13 |
| DMU | DECYL-BETA-D-MALTOPYRANOSIDE | 9 |
| URI | URIDINE | 5 |
| RBV | 1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide | 4 |
| U56 | N-hydroxycytidine | 3 |
| U7I | 2'-deoxy-2'-fluoro-2'-methyluridine | 3 |
| 5UD | 5-FLUOROURIDINE | 1 |
| ADN | ADENOSINE | 1 |
| CTN | 4-AMINO-1-BETA-D-RIBOFURANOSYL-2(1H)-PYRIMIDINONE | 1 |
| GEO | GEMCITABINE | 1 |
| P0C | 6-methyl-3-(beta-D-ribofuranosyl)-3,7-dihydro-2H-pyrrolo[2,3-d]pyrimidin-2-one | 1 |
| U08 | (2~{R},3~{R},4~{S},5~{R})-2-(4-azanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-(hydroxymethyl)-3,4-bis(oxidanyl)oxolane-2-carbonitrile | 1 |
| ZE8 | Zebularine | 1 |